Ocugen Inc. (NASDAQ:OCGN) saw a downside of -2.13% to close Monday at $0.54 after subtracting -$0.02 on the day. The 5-day average trading volume is 3,699,940 shares of the company’s common stock. It has gained $0.6200 in the past week and touched a new high 1 time within the past 5 days. An average of 4,660,255 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 7,180,316.
OCGN’s 1-month performance is -2.96% or -$0.0166 on its low of $0.5201 reached on 08/07/23. The company’s shares have touched a 52-week low of $0.44 and high of $2.95, with the stock’s rally to the 52-week high happening on 01/09/23. YTD, OCGN has lost -58.20% or -$0.7566 and has reached a new high 2 times. However, the current price is down -81.58% from the 52-week high price.
Insider Transactions
OCGN stock investors last saw insider trading activity on Jun 14.Musunuri Shankar (Chief Executive Officer) most recently sold 100,000 shares at $1.08 per share on Feb 16. This transaction cost the insider $108,000. Chief Executive Officer, Musunuri Shankar, sold 100,000 shares at a price of $1.28 on Jan 17. Then, on Dec 16, Chief Executive Officer Musunuri Shankar sold 95,809 shares at a price of $1.43 per share. This transaction amounted to $137,007.
Valuation Metrics
OCGN stock has a beta of 3.88. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 1.60.
Ocugen Inc.’s quick ratio for the recent period was 5.40, with the current ratio over the same period at 5.40.
Earnings Surprise
Ocugen Inc.’s cash and short-term investments amounted to $13.37 million against total debt of $6.28 million. Net income grew 1.28% to -$21.94 million, while revenue of -$21.92 million was 0.09% off the previous quarter. OCGN stock balance sheet for the recent quarter shows that total liabilities totaled 20.5 million, with total debt at $6.28 million. Shareholders hold equity totaling $226.43 million.
Let’s look briefly at Ocugen Inc. (OCGN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 07 August was 35.38% to suggest the stock is trending Neutral, with historical volatility in this time period at 43.66%.
The stock’s 5-day moving average is $0.5698, reflecting a -11.64% or -$0.0716 change from its current price. OCGN is currently trading -6.33% above its 20-day SMA, -42.27% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +16.38% and SMA200 by-66.87%.
Stochastic %K and %D was 18.11% and 26.52% and the average true range (ATR) pointed at 0.0313. The RSI (14) points at 41.89%, while the 14-day stochastic is at 22.87% with the period’s ATR at 0.0323. The stock’s 9-day MACD Oscillator is pointing at -0.0224 and -0.0244 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Ocugen Inc. (NASDAQ: OCGN), Chardan Capital Markets upgraded it to a Buy rating. They previously had a Neutral rating on the stock. Analysts offering their rating for OCGN stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate OCGN as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 6 have offered a “buy” rating.
What is OCGN’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $2.50 and a high of $8.00, with their median price target at $4.50. Looking at these predictions, the average price target given by analysts is for Ocugen Inc. (OCGN) stock is $4.58.
